Early Integrated Supportive Care Study for Gastrointestinal Cancer Patients
Currently at the BC Cancer Agency, oncologists decide when to refer a patient to the Pain
and Symptom Management/Palliative Care (PSMPC) team, and their decisions are made
subjectively and without standard guidelines/symptom assessment tools. Patients are often
referred late in their treatment. The PSMPC team sees patients in their own clinic,
separately from the oncologists, and do not often collaborate in a patient's care.
Early integration of palliative care into oncological care has been shown to improve quality
of life and to prolong survival, as well as to reduce inappropriately aggressive oncological
care at end of life, and reduce costs of care. We will test an early oncology-integrated
palliative care model, with the aims of determining whether 1) the introduction of PSMPC
support at the time of diagnosis leads to better symptom management and quality of life of
patients, 2) early integration of palliative care into medical oncology care reduces
aggressiveness of cancer treatment near end of life, and 3) a fully integrated service
delivery model is sustainable.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society